SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Krebs Biochemicals & Industries Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
524518 INE268B01013 -50.2613955 KREBSBIO 0 156.27 0 0 10
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales12.9814.8910.58
Other Operating Income0.000.000.00
Other Income 0.030.170.04
Total Income13.0115.0610.62
Total Expenditure 15.0715.7913.20
PBIDT-2.06-0.73-2.58
Interest 1.191.131.10
PBDT-3.25-1.86-3.68
Depreciation1.731.711.65
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-4.98-3.57-5.33
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-4.98-3.57-5.33
    
EPS (Unit Curr.)-2.31-1.66-2.47
EPS (Adj) (Unit Curr.)-2.31-1.66-2.47
Calculated EPS (Unit Curr.)-2.31-1.66-2.47
Calculated EPS (Adj) (Unit Curr.)-2.31-1.66-2.47
Calculated EPS (Ann.) (Unit Curr.)-9.23-6.63-9.89
Calculated EPS (Adj) (Ann.) (Unit Curr.)-9.23-6.63-9.89
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.5621.5621.56
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)-15.87-4.90-24.39
PBDTM(%)-25.04-12.49-34.78
PATM(%)-38.37-23.98-50.38